Fludarabine add-on therapy in interferon-beta-treated patients with multiple sclerosis experiencing breakthrough disease

Evaluation of No Evidence of Disease Activity in a 7-Year Longitudinal Multiple Sclerosis Cohort

(2015) Dalia L. Rotstein et al.   JAMA Neurology

Randomized study combining interferon and glatiramer acetate in multiple sclerosis

(2013) Fred D. Lublin et al.   ANNALS OF NEUROLOGY

Older and new purine nucleoside analogs for patients with acute leukemias

(2013) Pawel Robak et al.   CANCER TREATMENT REVIEWS

Fludarabine: A review of the clear benefits and potential harms

(2013) Joshua Lukenbill et al.   LEUKEMIA RESEARCH

Predictors of long-term outcome in multiple sclerosis patients treated with interferon beta

(2012) Robert A. Bermel et al.   ANNALS OF NEUROLOGY

Interferon-beta or azathioprine as add-on therapies in patients with active multiple sclerosis

(2012) Veronika Ticha et al.   NEUROLOGICAL RESEARCH

Treatment of Elderly Patients With Mantle Cell Lymphoma

(2011) Hanneke C. Kluin-Nelemans et al.   SEMINARS IN HEMATOLOGY

Cerebral pseudoatrophy or real atrophy after therapy in multiple sclerosis

(2010) Khoury Samia et al.   ANNALS OF NEUROLOGY

Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial

(2010) Mads Ravnborg et al.   LANCET NEUROLOGY

Combination therapy in multiple sclerosis

(2010) Devon Conway et al.   LANCET NEUROLOGY

MRI in multiple sclerosis: current status and future prospects

(2008) Rohit Bakshi et al.   LANCET NEUROLOGY